| Literature DB >> 30454957 |
Arantxa Aliaga1, Oriol Cunillera2, María Del Carmen Amador3, Mercedes Aliaga4, Martí Arquerons5, Jesús Almeda6.
Abstract
OBJECTIVE: To study the relationship between maternal affective disorders (AD) before and during pregnancy, and pre-term birth.Entities:
Keywords: Affective disorders; Antidepresivos; Antidepressive agents; Embarazo; Factores de riesgo; Infant; Pregnancy; Premature; Recién nacido Prematuro; Risk factors; Trastornos psicóticos afectivos
Mesh:
Substances:
Year: 2018 PMID: 30454957 PMCID: PMC6930948 DOI: 10.1016/j.aprim.2018.06.009
Source DB: PubMed Journal: Aten Primaria ISSN: 0212-6567 Impact factor: 1.137
Descriptive global and bivariate analysis of maternal characteristics, previous pregnancies, and labour regarding preterm birth.
| Missing | Global ( | Normal ( | Preterm ( | ||
|---|---|---|---|---|---|
| Agea | 0 | 31.00 [27.00, 35.00] | 31.00 [27.00, 35.00] | 32.00 [28.00, 36.00] | <0.001 |
| MEDEA deprivation index | 0 | 0.038 | |||
| Rural | 15,487 (15.17%) | 14,804 (15.14%) | 683 (15.94%) | ||
| Quintile 1 (less disadvantaged) | 9,553 (9.36%) | 9,188 (9.39%) | 365 (8.52%) | ||
| Quintile 2 | 24,866 (24.36%) | 23,864 (24.40%) | 1,002 (23.38%) | ||
| Quintile 3 | 14,508 (14.21%) | 13,913 (14.23%) | 595 (13.88%) | ||
| Quintile 4 | 17,236 (16.88%) | 16,514 (16.89%) | 722 (16.85%) | ||
| Quintile 5 (more disadvantaged) | 20,436 (20.02%) | 19,517 (19.96%) | 919 (21.44%) | ||
| Partnership status | 0 | 0.468 | |||
| Single | 37,279 (36.52%) | 35,691 (36.49%) | 1,588 (37.05%) | ||
| Partner | 64,807 (63.48%) | 62,109 (63.51%) | 2,698 (62.95%) | ||
| Term deliveryb | 1,334 | 1.07 (1.01) | 1.08 (1.01) | 0.81 (0.99) | <0.001 |
| Preterm deliveryb | 1,334 | 0.03 (0.19) | 0.02 (0.16) | 0.22 (0.52) | <0.001 |
| Abortionb | 1,334 | 0.46 (0.79) | 0.46 (0.79) | 0.53 (0.88) | <0.001 |
| Live bornb | 1,334 | 1.08 (1.01) | 1.09 (1.00) | 0.98 (1.02) | <0.001 |
| Inter-pregnancy interval | 0 | <0.001 | |||
| (>18 months) | 85,813 (84.06%) | 82,292 (84.14%) | 3,521 (82.15%) | ||
| [12–18] months | 5,334 (5.23%) | 5,102 (5.22%) | 232 (5.41%) | ||
| [0–12] months | 10,939 (10.72%) | 10,406 (10.64%) | 533 (12.44%) | ||
| Type | 14,439 | <0.001 | |||
| Eutocic | 56,808 (64.81%) | 54,974 (65.36%) | 1,834 (51.81%) | ||
| Dystocic | 30,839 (35.19%) | 29,133 (34.64%) | 1,706 (48.19%) | ||
| Number of foetuses | 0 | <0.001 | |||
| 1 | 100,624 (98.57%) | 96,872 (99.05%) | 3,752 (87.54%) | ||
| 2 | 1,462 (1.43%) | 928 (0.95%) | 534 (12.46%) | ||
Qualitative variables are expressed in absolute and relative frequency for each category, and numeric variables are expressed in (a) median and interquartile range, or (b) media and standard deviation. Variable distribution between preterm and term labour groups is compared by Wilcoxon test for numeric variables, and Chi-square test for categorical variables.
[ll1]Health conditions before birth. Descriptive and bivariate analysis according to preterm birth.
| Previous history | During pregnancy | |||||||
|---|---|---|---|---|---|---|---|---|
| Global | Normal ( | Preterm ( | Global | Normal ( | Preterm ( | |||
| Affective disorder | 1,631 (1.60%) | 1,533 (1.57%) | 98 (2.29%) | <0.001 | 3,571 (3.50%) | 3,387 (3.46%) | 184 (4.29%) | 0.004 |
| Anxiety disorder and obsessive-compulsive disorder | 6,775 (6.64%) | 6,427 (6.57%) | 348 (8.12%) | <0.001 | 14,996 (14.69%) | 14,294 (14.62%) | 702 (16.38%) | 0.002 |
| Dissociative and stress disorder | 746 (0.73%) | 695 (0.71%) | 51 (1.19%) | <0.001 | 1,922 (1.88%) | 1,818 (1.86%) | 104 (2.43%) | 0.009 |
| Smoker | 7,962 (7.80%) | 7,623 (7.79%) | 339 (7.91%) | 0.806 | 22,533 (22.07%) | 21,491 (21.97%) | 1,042 (24.31%) | <0.001 |
| Non-smoker | 2,455 (2.40%) | 2,372 (2.43%) | 83 (1.94%) | 0.046 | 47,962 (46.98%) | 46,045 (47.08%) | 1,917 (44.73%) | 0.003 |
| Mental and behavioural disorders due to use of tobacco | 2,869 (2.81%) | 2,756 (2.82%) | 113 (2.64%) | 0.511 | 15,961 (15.63%) | 15,217 (15.56%) | 744 (17.36%) | 0.002 |
| Eating disorder | 207 (0.20%) | 192 (0.20%) | 15 (0.35%) | 0.044 | 833 (0.82%) | 803 (0.82%) | 30 (0.70%) | 0.438 |
| Mental and behavioural disorders due to use of psychoactive substances | 125 (0.12%) | 120 (0.12%) | 5 (0.12%) | 1.000 | 451 (0.44%) | 422 (0.43%) | 29 (0.68%) | 0.024 |
| Mental and behavioural disorders due to use of alcohol | 69 (0.07%) | 63 (0.06%) | 6 (0.14%) | 0.118 | 277 (0.27%) | 250 (0.26%) | 27 (0.63%) | <0.001 |
| Divorce | 287 (0.28%) | 275 (0.28%) | 12 (0.28%) | 1.000 | 1,468 (1.44%) | 1,387 (1.42%) | 81 (1.89%) | 0.013 |
| In Vitro fertilization | 147 (0.14%) | 135 (0.14%) | 12 (0.28%) | 0.028 | 573 (0.56%) | 503 (0.51%) | 70 (1.63%) | <0.001 |
| Caesarean | 1,033 (1.01%) | 973 (0.99%) | 60 (1.40%) | 0.012 | 334 (0.33%) | 322 (0.33%) | 12 (0.28%) | 0.677 |
| Twin pregnancy | 39 (0.04%) | 36 (0.04%) | 3 (0.07%) | 0.491 | 169 (0.17%) | 114 (0.12%) | 55 (1.28%) | <0.001 |
| Placental pathology | 13 (0.01%) | 12 (0.01%) | 1 (0.02%) | 1.000 | 23 (0.02%) | 19 (0.02%) | 4 (0.09%) | 0.008 |
| Placenta praevia, detachment, antepartum haemorrhage | 780 (0.76%) | 752 (0.77%) | 28 (0.65%) | 0.446 | 2,623 (2.57%) | 2,413 (2.47%) | 210 (4.90%) | <0.001 |
| Pre-eclampsia-Eclampsia | 417 (0.41%) | 383 (0.39%) | 34 (0.79%) | <0.001 | 1,046 (1.02%) | 892 (0.91%) | 154 (3.59%) | <0.001 |
| Hypertension | 110 (0.11%) | 101 (0.10%) | 9 (0.21%) | 0.065 | 852 (0.83%) | 751 (0.77%) | 101 (2.36%) | <0.001 |
| Glomerular disease, tubulo-interstitial disease, lithiasis, other | 1,432 (1.40%) | 1,366 (1.40%) | 66 (1.54%) | 0.475 | 1,608 (1.58%) | 1,524 (1.56%) | 84 (1.96%) | 0.045 |
| Metabolic disorder | 310 (0.30%) | 293 (0.30%) | 17 (0.40%) | 0.323 | 3,829 (3.75%) | 3,603 (3.68%) | 226 (5.27%) | <0.001 |
| Viral Hepatitis | 270 (0.26%) | 249 (0.25%) | 21 (0.49%) | 0.005 | 769 (0.75%) | 735 (0.75%) | 34 (0.79%) | 0.827 |
| Diabetes Mellitus | 49 (0.05%) | 44 (0.04%) | 5 (0.12%) | 0.082 | 372 (0.36%) | 333 (0.34%) | 39 (0.91%) | <0.001 |
| Toxic liver disease | 5 (0.00%) | 3 (0.00%) | 2 (0.05%) | 0.004 | 8 (0.01%) | 7 (0.01%) | 1 (0.02%) | 0.772 |
| Sexual transmission disease | 251 (0.25%) | 233 (0.24%) | 18 (0.42%) | 0.028 | 789 (0.77%) | 761 (0.78%) | 28 (0.65%) | 0.410 |
| Viral disease | 14,230 (13.94%) | 13,577 (13.88%) | 653 (15.24%) | 0.013 | 5,219 (5.11%) | 4,982 (5.09%) | 237 (5.53%) | 0.218 |
| Mycosis (Aspergillus, etc.) | 47 (0.05%) | 46 (0.05%) | 1 (0.02%) | 0.731 | 96 (0.09%) | 86 (0.09%) | 10 (0.23%) | 0.005 |
| Blood disorder | 58 (0.06%) | 52 (0.05%) | 6 (0.14%) | 0.045 | 479 (0.47%) | 459 (0.47%) | 20 (0.47%) | 1.000 |
| Congenital malformation | 126 (0.12%) | 119 (0.12%) | 7 (0.16%) | 0.591 | 1,127 (1.10%) | 1,062 (1.09%) | 65 (1.52%) | 0.010 |
| Cerebral palsy and other | 4 (0.00%) | 4 (0.00%) | 0 (0.00%) | 1.000 | 29 (0.03%) | 25 (0.03%) | 4 (0.09%) | 0.035 |
| Vestibular disorder | 2325 (2.28%) | 2,208 (2.26%) | 117 (2.73%) | 0.048 | 1,220 (1.20%) | 1,165 (1.19%) | 55 (1.28%) | 0.638 |
| Benign tumour | 493 (0.48%) | 452 (0.46%) | 41 (0.96%) | <0.001 | 2319 (2.27%) | 2,198 (2.25%) | 121 (2.82%) | 0.015 |
| Tumour | 37 (0.04%) | 35 (0.04%) | 2 (0.05%) | 1.000 | 113 (0.11%) | 102 (0.10%) | 11 (0.26%) | 0.007 |
Digestive system, respiratory, intrathoracic, bone and cartilage, lipomatous, mesothelial, conjunctive, ovarian, uterus, meningeal, encephalous.
Absolute and relative frequency of women presenting the characteristic are shown for each variable. Variable distribution between preterm and term labour groups is compared by Chi-square test. This description and test are conducted on variables prior to pregnancy (previous history) and variables during pregnancy.
Use of medication prior to birth. Descriptive and bivariate analysis according to preterm birth.
| Previous history | During pregnancy | |||||||
|---|---|---|---|---|---|---|---|---|
| Global ( | Normal ( | Preterm ( | Global ( | Normal ( | Preterm ( | |||
| Anticoagulants | 3,548 (3.48%) | 3,385 (3.46%) | 163 (3.80%) | 0.249 | 1,770 (1.73%) | 1,578 (1.61%) | 192 (4.48%) | <0.001 |
| Antidepressants | 11,529 (11.29%) | 10,962 (11.21%) | 567 (13.23%) | <0.001 | 4,143 (4.06%) | 3,936 (4.02%) | 207 (4.83%) | 0.010 |
| Androgens | 21,109 (20.68%) | 20,253 (20.71%) | 856 (19.97%) | 0.252 | 9,125 (8.94%) | 8,589 (8.78%) | 536 (12.51%) | <0.001 |
| Antipsychotics | 2,179 (2.13%) | 2,070 (2.12%) | 109 (2.54%) | 0.066 | 407 (0.40%) | 374 (0.38%) | 33 (0.77%) | <0.001 |
| ACEI | 382 (0.37%) | 337 (0.34%) | 45 (1.05%) | <0.001 | 191 (0.19%) | 160 (0.16%) | 31 (0.72%) | <0.001 |
| Progestagens | 18,744 (18.36%) | 17,993 (18.40%) | 751 (17.52%) | 0.153 | 8,191 (8.02%) | 7,704 (7.88%) | 487 (11.36%) | <0.001 |
Absolute and relative frequency of use, are shown for each medication. Variable distribution between preterm and term labour groups is compared by Chi-square test. This description and test are conducted on use of medication prior to pregnancy (previous history) and during pregnancy.
ACEI = angiotensin converting enzyme inhibitors.
Multivariate analysis on health conditions prior and during pregnancy and preterm birth.
| Odds Ratio [CI95%] | |||
|---|---|---|---|
| (Independent term) | 0.00 [0.00, 0.00] | <0.001 | |
| 1.07 [0.90, 1.26] | 0.413 | ||
| | Term birth | 0.54 [0.45, 0.63] | <0.001 |
| Preterm birth | 4.68 [4.00, 5.45] | <0.001 | |
| Abortion | 1.07 [1.03, 1.11] | 0.001 | |
| Live-born | 1.44 [1.21, 1.71] | <0.001 | |
| | Rural | -reference- | |
| Quintile 1 (less disadvantaged) | 0.92 [0.80, 1.05] | 0.231 | |
| Quintile 2 | 0.92 [0.82, 1.02] | 0.117 | |
| Quintile 3 | 0.91 [0.81, 1.03] | 0.144 | |
| Quintile 4 | 0.98 [0.88, 1.10] | 0.789 | |
| Quintile 5 (more disadvantaged) | 1.09 [0.97, 1.21] | 0.136 | |
| | Without short interval | -reference- | |
| 12 to 18 months | 0.98 [0.84, 1.14] | 0.822 | |
| Under 12 months | 1.19 [1.07, 1.32] | <0.001 | |
| | 14.32 [12.37, 16.55] | <0.001 | |
| | 1.32 [1.04, 1.64] | 0.017 | |
| | 1.41 [1.02, 1.91] | 0.030 | |
| | 0.72 [0.56, 0.91] | 0.007 | |
| | 1.91 [1.05, 3.20] | 0.022 | |
| | 1.79 [1.04, 2.90] | 0.025 | |
| | 12.75 [1.53, 83.93] | 0.009 | |
| | 1.70 [1.18, 2.38] | 0.003 | |
| | |||
| Anticoagulants | 1.39 [1.15, 1.67] | <0.001 | |
| Androgens | 1.23 [1.10, 1.36] | <0.001 | |
| Antipsychotics | 1.61 [1.05, 2.36] | 0.021 | |
| ACEI | 1.88 [1.13, 3.03] | 0.012 | |
| | |||
| Dissociative and stress disorder | 1.24 [0.99, 1.53] | 0.051 | |
| Non-smoker | 0.92 [0.86, 0.98] | 0.010 | |
| Mental and behavioural disorders due to use of alcohol | 1.92 [1.20, 2.93] | 0.004 | |
| In Vitro fertilization | 1.46 [1.05, 2.00] | 0.021 | |
| Placenta praevia, detachment, antepartum haemorrhage | 1.80 [1.53, 2.11] | <0.001 | |
| Eclampsia | 3.22 [2.63, 3.90] | <0.001 | |
| Hypertension | 2.15 [1.64, 2.79] | <0.001 | |
| Glomerular disease, tubulo-interstitial disease, lithiasis, other | 1.20 [0.94, 1.52] | 0.128 | |
| Metabolic disorder | 1.30 [1.11, 1.51] | <0.001 | |
| Diabetes Mellitus | 2.31 [1.56, 3.31] | <0.001 | |
| Mycosis (Aspergillus, etc.) | 3.35 [1.60, 6.26] | <0.001 | |
| Congenital malformation | 1.24 [0.94, 1.61] | 0.122 | |
| Cerebral palsy and other | 2.72 [0.74, 7.74] | 0.088 | |
| Tumour | 2.38 [1.12, 4.51] | 0.014 | |
Digestive system, respiratory, intrathoracic, bone and cartilage, lipomatous, mesothelial, conjunctive, ovarian, uterus, meningeal, encephalous.
ACEI = angiotensin converting enzyme inhibitors.
Results of the multivariate logistic regression model on preterm birth. Final model obtained by “stepwise backwards” variable selection model based on the “Akaike Information Criteria” from all statistically significant and clinically relevant variables on the bivariate analysis, as explicative variables. Results are presented in “Odds Ratio”, with a confidence interval of 95%, estimated as the exponential of the obtained coefficient from the multivariate logistic regression model, and p-value of its statistical significance.